Dr. Bleday dives into the findings of a recent study on role of organized religion in treatment with Professor Tyler VanderWeele. Dr. VanderWeele is the John L. Loeb and Frances Lehman Loeb Professor of Epidemiology at the Harvard School of Public Health.

Bleday and Meyerhardt discuss a trend in colorectal cancer cases involving younger patients, and some resources available for patients at the cancer care center.

With Dr. Leslie Lee

Episode #14 with Kimmie Ng.

Dr. Ron Bleday speaks with two guests to discuss colorectal cancer care in the island setting of Bermuda. His guests include Dr. Chris Fosker and Dr. Boris Vestweber.

Visit Howwetreat.org for full blog post.

Drs. Bleday & Meyerhardt speak with Dr. Kevin Elias about Enhanced Recovery After Surgery methods and studies taking place right now in reducing stress on the patient's body pre-surgery. Even eating, hydrating, and carbohydrates are involved in prepping for common surgeries CRC doctors will want to learn more about.

Episode #11: Watch & Wait Protocol by Dana-Farber/Brigham and Women’s Cancer Center

Dr. Bleday and Dr. Meyerhardt discuss the International Duration Evaluation of Adjuvant chemotherapy project (IDEA) with Dr. Axel Grothey from the Mayo Clinic. Interview was recorded at the 2017 ASCO Conference in Chicago.

This episode features discussion on Heated Intraperitoneal Chemotherapy (HIPEC) treatment. The experts joining the podcast to discuss this type of care are Dr. Nelya Melnitchouk and Dr. Tom Abrams from the GI team at the Dana Farber/Brigham and Women's Cancer Center in Boston.

HIPEC differs from other treatments because of the specific and targeted delivery method. The chemo does not circulate through the entire body during HIPEC. It only is directed at the cancerous cells in the abdomen area.

This episode features discussion on Heated Intraperitoneal Chemotherapy (HIPEC) treatment. The experts joining the podcast to discuss this type of care are Dr. Nelya Melnitchouk and Dr. Tom Abrams from the GI team at the Dana Farber/Brigham and Women's Cancer Center in Boston.

HIPEC differs from other treatments because of the specific and targeted delivery method. The chemo does not circulate through the entire body during HIPEC. It only is directed at the cancerous cells in the abdomen area.